PharmaShots Weekly Snapshot (November 05 - 09 Nov, 2018)
Published: 5 Nov, 2018 |Tags: Merck, Signs, Clinical Trial, Collaboration, FLX Bio, Combination Therapy, Keytruda
- Amgen to Present Long-Term Safety-Efficacy Data of Repatha (evolocumab) in Multiple studies, at AHA 2018
- Abeona Signs Exclusive License Agreement with Regenxbio to Develop and Commercialize NAV AAV9 Vector